is tirzepatide on the shortage list Eli Lilly's weight loss drug no longer in FDA's GLP-1 decision kicks off

doi: 10.1210/clinem/dgab359

475 adults with type 2 diabetes and inadequate glycemic control while treated with once-daily insulin glargine with or without metformin were enrolled from August 30, 2019, to March 20, 2020

Unfortunately, in some conditions and diseases these parameters are impacted

GLP-1R expression in the kidneys drives direct renoprotective effects that work independently of glucose and weight changes

Two-year follow-up of intracorneal ring segments implantation in adolescent patients with keratoconus

Infused with glutathione, our skin supplement helps reduce blemish to promote a clear, even toned complexion